SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTriple Point Ve Regulatory News (TPV)

Share Price Information for Triple Point Ve (TPV)

Share Price is delayed by 15 minutes
Get Live Data
86.00    0.00 (0.00%)
Bid:
84.50
Ask:
87.50
Spread: 3.00 (3.55%)
Market Cap: £114.69m
TPV Live PriceLast checked at - London Stock Exchange

Intraday Triple Point Ve Share Chart

Interim Management Statement

17 Jan 2013 09:30

RNS Number : 7695V
TP70 VCT Plc
17 January 2013
 



 

 

 

 

 

TP70 VCT plc

 

16 January 2013

 

Interim Management Statement for the quarter ended 30 November 2012

 

TP70 VCT plc ("the Company") submits its Interim Management Statement for the period ended 30 November 2012. This constitutes the Company's second Interim Management Statement for the financial year ending 28 February 2013, as required by the UK Listing Authority's Disclosure and Transparency Rule 4.3.

 

Net assets at 30 November 2012 comprised:

 

30 November 2012

31 August 2012

29 February 2012

Unaudited

Unaudited

Audited

£'000

% investments

£'000

% investments

£'000

% investments

VCT qualifying unquoted investments

4,827

90.4

4,827

74.4

17,636

77.3

 

Non VCT qualifying investments:

Unquoted investments

-

-

431

6.6

-

-

Money Market

-

-

500

7.7

-

-

GAM Diversity

-

-

-

-

3,289

14.4

Cash and cash equivalents

514

9.6

734

11.3

1,880

8.3

Total Investments

5,341

100.0

6,492

100.0

22,805

100.0

Other assets & liabilities

(239)

(260)

(101)

Net assets

5,102

6,232

22,704

Net asset value per share

15.95p

19.48p

70.97p

Realisation of Investments

The Board is pleased to announce that the Company's exit strategy is well advanced. The Company realised £12.8 million of qualifying investments since the year ended 29 February 2012 and is in advanced negotiations to conclude the realisation of its remaining investments. Its exposure to GAM Diversity held through a note executed with Julius Baer was closed and proceeds of £3.3 million were also received during the period since the year end.

 

 

Distributions

As a result of the realisations described above a dividend of 52.4p per share was paid to shareholders on 25 May 2012 and 3.59p per share was paid on 21 September 2012, which taken together with the period end net asset value of 15.95p is equal to 71.94p per share, an increase of 0.97p over the position at 29 February 2012.

 

On 21 December the Board announced payment of a further dividend of 4.38p to be paid on 18 January 2013. The expectation is that a 4th more substantial dividend will be announced before the end of January.

 

 

Remaining Investments

It is expected that the realisation proceeds from the remaining investments will be not less than book value.

 

The remaining investments can be analysed as follows:

 

Electricity Generation

Industry Sector

Cinema Digitisation

Solar PV

Anaerobic Digestion

Total Qualifying Investments

Qualifying Investments £'000

176

3,317

1,334

4,827

Qualifying Investments %

3.65%

68.72%

27.63%

100.00%

 

 

Material Events and Transactions

During the period no shares were issued and no shares were purchased by the Company for cancellation.

 

 

Further Information

For further information, please contact Claire Ainsworth or Chris Tottle at Triple Point Investment Management LLP on 0207 201 8989.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRMLTMBTBMPJ
Date   Source Headline
17th Mar 202512:20 pmRNSIssue of Equity and Total Voting Rights
11th Mar 20253:13 pmRNSTransaction in Own Shares
11th Mar 202510:42 amRNSIssue of Equity and Total Voting Rights
3rd Mar 202510:46 amRNSTotal Voting Rights
26th Feb 202512:14 pmRNSIssue of Equity and Total Voting Rights
13th Feb 20259:10 amRNSOffer for Subscription - over-allotment facility
10th Feb 20252:10 pmRNSIssue of Equity and Total Voting Rights
30th Jan 20252:11 pmRNSVenture Share Class Net Asset Value
6th Jan 20257:00 amRNSDividend Declaration
2nd Jan 20257:00 amRNSTotal Voting Rights
23rd Dec 20247:00 amRNSOffer for Subscription - over-allotment facility
19th Dec 20243:07 pmRNSIssue of Equity and Total Voting Rights
2nd Dec 20247:05 amRNSIssue of Equity and Total Voting Rights
2nd Dec 20247:00 amRNSTotal Voting Rights
18th Nov 20244:00 pmRNSTransaction in Own Shares
12th Nov 20242:13 pmRNSIssue of Equity and Total Voting Rights
29th Oct 20244:05 pmRNSIssue of Equity and Total Voting Rights
23rd Oct 20247:00 amRNSResults for the six months ended 31 August 2024
2nd Oct 202410:59 amRNSDirector Declaration
30th Sep 20247:00 amRNSDividend Declaration
26th Sep 20243:30 pmRNSResult of General Meeting
4th Sep 202412:32 pmRNSPublication of a Prospectus and Circular
2nd Sep 202412:00 pmRNSTotal Voting Rights
9th Aug 20241:30 pmRNSTransaction in Own Shares
1st Aug 202410:30 amRNSTotal Voting Rights
1st Aug 20247:00 amRNSIntention to Launch an Offer for Subscription
31st Jul 20243:57 pmRNSIssue of Equity and Total Voting Rights
24th Jul 20247:00 amRNSVenture Share Class Net Asset Value
23rd Jul 20242:09 pmRNSResult of Annual General Meeting
4th Jul 20244:58 pmRNSTransaction in Own Shares
1st Jul 20244:42 pmRNSChange of Registered Office
1st Jul 20244:36 pmRNSTotal Voting Rights
27th Jun 20243:30 pmRNSIssue of Equity and Total Voting Rights
12th Jun 20245:29 pmRNSAnnual Financial Report and Notice of AGM
3rd Jun 20247:00 amRNSFinal Results for the year ended 29 February 2024
1st May 20247:00 amRNSTotal Voting Rights
5th Apr 20242:48 pmRNSIssue of Equity and Total Voting Rights
4th Apr 20243:01 pmRNSIssue of Equity and Total Voting Rights
2nd Apr 20242:00 pmRNSIssue of Equity and Total Voting Rights
2nd Apr 20247:00 amRNSTotal Voting Rights
26th Mar 20247:00 amRNSOffer for Subscription - over-allotment facility
18th Mar 20247:00 amRNSIssue of Equity and Total Voting Rights
5th Mar 20242:50 pmRNSIssue of Equity and Total Voting Rights
13th Feb 202412:30 pmRNSIssue of Equity and Total Voting Rights
9th Feb 20247:00 amRNSOffer for Subscription - over-allotment facility
8th Feb 20243:30 pmRNSVenture Share Class Net Asset Value
8th Feb 20242:00 pmRNSDirectorate Change
4th Jan 20249:41 amRNSTotal Voting Rights
3rd Jan 20247:00 amRNSDividend Declaration
21st Dec 20231:33 pmRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.